Long-term outcomes after Roux-en-Y gastric bypass: 10- to 13-year data.

Area of Science:

• Bariatric Surgery
• Metabolic and Bariatric Surgery
• Surgical Outcomes

Background:

• Roux-en-Y gastric bypass (RYGB) shows promise for sustained weight loss and co-morbidity improvement in short-to-mid-term follow-ups.
• Limited long-term data exists, with some studies being outdated or using different surgical techniques.

Purpose of the Study:

• To evaluate long-term outcomes of RYGB, focusing on weight loss, co-morbidity remission, nutritional status, and complication rates.
• To provide updated insights into the durability and safety of RYGB over a decade post-surgery.

Main Methods:

• A retrospective study involving patients who underwent RYGB at least 10 years prior.
• Data collected via chart review, office visits, and telephone interviews.
• Exclusion criteria included revisional surgery, with outcomes tracked for weight loss, co-morbidities, complications, and nutritional deficiencies.

Main Results:

• Mean excess weight loss (%EWL) was 58.9% at over 10 years post-RYGB.
• Significant co-morbidity remission rates observed: 46% for hypertension and hyperlipidemia, 58% for diabetes mellitus.
• High incidence of long-term complications (19.5%) and nutritional deficiencies (87%), with 9% requiring revisional surgery for weight regain.

Conclusions:

• RYGB demonstrates significant and sustainable weight loss, particularly in non-super-obese individuals.
• Co-morbidities show substantial improvement and remission a decade after RYGB.
• Nutritional deficiencies are nearly universal, highlighting the need for lifelong monitoring.